Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines

A marked antitumour efficacy is currently obtained by oxaliplatin (LOHP)–fluorouracil (FU)–folinic acid (FA) combination and by CPT11–FU–FA combination. Logically, the triple association LOHP, CPT11 and FUFA will be soon tested in cancer patients. The aim of the present study was to compare two sche...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Fischel, J-L, Rostagno, P, Formento, P, Dubreuil, A, Etienne, M-C, Milano, G
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2001
Assuntos:
Regular Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363774/
https://ncbi.nlm.nih.gov/pubmed/11207057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1600
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares